MENU
RGEN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Repligen (RGEN) Ownership - Who owns Repligen?
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
41 Seyon Street
Phone
+1 781 250-0111
Employees
1783
Web
https://www.repligen.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
6.27B
P/E Ratio
521.44
Total Cash
697.23M
Projected Growth
N/A
Total Debt
683.7M
Revenue
650.43M
Risk (Beta)
0.91
Dividend Yield
N/A
Total Cash/Share
12.39
Total Debt/Equity
N/A
Revenue/Share
12.01 USD as % of share price
Fundamentals
RGEN
Capitalization
6.27B
P/E Ratio
521.44
Risk (Beta)
0.91
Dividend Yield
N/A
Total Cash
697M
Total Cash/Share
12.39
Total Debt
684M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
12.01%
Revenue
650M
ROE
N/A
Book Value
1.99B
P/B Ratio
3.04
Cash Flow
N/A
Earnings
-0.42
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
562K
Current Ratio
6.79
Current Revenue Per Employee
95147.36
Dividends Per Share - Security
N/A
EBITDA
86.6M
Float
N/A
Float - Current
N/A
Gross Income Margin
53.65
Revenue To Assets
-0.81
Shares Held By Institutions
18.9B
Shares Outstanding - Current
56.3M
Total Liabilities
867M
Total Volume MTD
N/A
Value
-1
Gain YTD
-22.586
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RGEN showed earnings on July 29, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a developer of biologic drugs
Industry PharmaceuticalsOther
Profile
Fundamentals
Details
Industry
Biotechnology
Address
41 Seyon Street
Phone
+1 781 250-0111
Employees
1783
Web
https://www.repligen.com